These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11569400)

  • 1. Defects in deletional tolerance of CD8+ T cells in autoimmune diabetes.
    Kreuwel HT; Sherman LA
    Curr Dir Autoimmun; 2001; 4():123-43. PubMed ID: 11569400
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
    Baumann EE; Buckingham F; Herold KC
    Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8
    Reeves PLS; Rudraraju R; Wong FS; Hamilton-Williams EE; Steptoe RJ
    Eur J Immunol; 2017 Sep; 47(9):1550-1561. PubMed ID: 28665492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells.
    Hugues S; Mougneau E; Ferlin W; Jeske D; Hofman P; Homann D; Beaudoin L; Schrike C; Von Herrath M; Lehuen A; Glaichenhaus N
    Immunity; 2002 Feb; 16(2):169-81. PubMed ID: 11869679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice.
    Arreaza G; Salojin K; Yang W; Zhang J; Gill B; Mi QS; Gao JX; Meagher C; Cameron M; Delovitch TL
    Clin Immunol; 2003 May; 107(2):103-15. PubMed ID: 12763479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse.
    Kay TW; Chaplin HL; Parker JL; Stephens LA; Thomas HE
    Res Immunol; 1997 Jun; 148(5):320-7. PubMed ID: 9352596
    [No Abstract]   [Full Text] [Related]  

  • 7. Questions about NOD mouse diabetes.
    Cohen IR
    Res Immunol; 1997 Jun; 148(5):286-91. PubMed ID: 9352591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune disease. Gadding around the beta cell.
    Cooke A
    Curr Biol; 1994 Feb; 4(2):158-60. PubMed ID: 7953521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing the action of IL-2 in tolerance to islet-specific antigen.
    Liston A; Siggs OM; Goodnow CC
    Immunol Cell Biol; 2007 Jun; 85(4):338-42. PubMed ID: 17372610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel function of islet-derived CD8+T cells in initiating and developing autoimmune insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
    Amano K; Yokono K; Hasegawa Y; Taki T; Tominaga Y; Yoneda R; Nagata M; Kasuga M
    Diabetes Res Clin Pract; 1995 Jun; 28(3):161-72. PubMed ID: 8529494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune regulation by regulatory T cells].
    Nakano N
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():414-9. PubMed ID: 15861690
    [No Abstract]   [Full Text] [Related]  

  • 14. NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates.
    Kukreja A; Maclaren NK
    Diabetes Technol Ther; 2002; 4(3):323-33. PubMed ID: 12165171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x.
    Lamhamedi-Cherradi SE; Luan JJ; Eloy L; Fluteau G; Bach JF; Garchon HJ
    Diabetologia; 1998 Feb; 41(2):178-84. PubMed ID: 9498651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes.
    Serreze DV; Silveira PA
    Curr Dir Autoimmun; 2003; 6():212-27. PubMed ID: 12408054
    [No Abstract]   [Full Text] [Related]  

  • 17. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
    Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
    J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.
    Thiessen S; Serra P; Amrani A; Verdaguer J; Santamaria P
    Diabetes; 2002 Feb; 51(2):325-38. PubMed ID: 11812739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.